S&P 500
7,614.80
-0.10%
Dow Jones
51,325.00
-0.09%
Nasdaq 100
30,645.00
-0.23%
Russell 2000
2,930.03
-0.10%
FTSE 100
10,376.30
-0.11%
Nikkei 225
68,456.70
+1.41%

Health and Healthcare

The $1,000 Genome Finally Arrives (LIFE)

Photo of Jon C. Ogg
By Jon C. Ogg Updated Published

Invalid Image
Personalized medicine is coming… if you can afford it.  The quest for the $1,000 genomic map has been a race and it appears to be closer and closer.  News is out from Life Technologies that is unveiling the Benchtop Ion Proton™ Sequencer out at the Consumer Electronics Show in Las Vegas, Nevada this week.

Life Tech noted that the Ion Proton™ Sequencer is designed to decode a human genome in one day for $1,000.00 and it is being exhibited now through this Friday.

As a reminder, Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems, Inc.  The company’s website for this product description notes:

Powered by Ion Torrent™ semiconductor chip technology, the Ion Proton™ Sequencer is the first benchtop next-generation sequencer to offer fast, affordable human genome and human exome sequencing. Powered by the next generation of semiconductor sequencing technology and offering a similar single-day workflow to the Ion PGM™ Sequencer, the Ion Proton™ Sequencer promises to change the way scientists look at genomics.

Now for the big question… Why do they have to tack on all the extra years on the backside of life?  This news does not bring about the cure for cancer, but it is one step closer to personalized medicine and treating each patient individually rather than just based upon a broader protocol.

JON C. OGG

Follow 24/7 Wall St. on Google
Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. www.247wallst.com.

Continue Reading

Health Care In The Genomic Age
Trey Thoelcke |

Health Care In The Genomic Age

by Brett Winton, Director of Research We believe investors need to understand how genomics innovation can be a catalyst for…

Douglas A. McIntyre |

Illumina Rejects Roche

Genetic biotech company Illumini (NASDAQ: ILMN) rejected an offer, now hostile, made by drug giant Roche. The Illimina board said…

Proteomics Could Be the Next ‘Omics Frontier
Trey Thoelcke |

Proteomics Could Be the Next ‘Omics Frontier

By Simon Barnett, Analyst The ‘omics revolution describes how technology is transforming our understanding of the fundamental building blocks of…

Jon C. Ogg |

Big Day For Bio-Winners (GNOM, PACB, REGN, SRLS)

Monday is a strange day for the movers and shakers, but the biotech and biohealth space has four clear winners…

RBC Says These 4 Top Biotechs Could Have Big Upside Potential
Lee Jackson |

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

6 Top Contrarian Calls With Markets at Record Highs
Lee Jackson |

6 Top Contrarian Calls With Markets at Record Highs

These six stocks look like solid bets for investors seeking ideas to add to their portfolios for the balance of…

The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today
Rich Duprey |

The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today

What if the biggest winners in biotech weren’t the ones promising miracle cures, but the ones quietly supplying the picks…

Personalis (PSNL) Is Pioneering Population-Sequencing-as-a-Service
Trey Thoelcke |

Personalis (PSNL) Is Pioneering Population-Sequencing-as-a-Service

By Simon Barnett | @sbarnettARK In a quarter of record revenue growth and new product launches, Personalis (PSNL) – a burgeoning deep genomics company…

Lee Jackson |

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation…

Top Gaining Stocks

Hewlett Packard Enterprise
HPE • Vol: 153,197,465
Enphase Energy
ENPH • Vol: 8,360,053
Corning
GLW • Vol: 18,152,646
Alexandria Real Estate Equities
ARE • Vol: 4,337,015
Aptiv
APTV • Vol: 6,761,325

Top Losing Stocks

Trade Desk
TTD • Vol: 21,905,513
Intuit
INTU • Vol: 7,383,018
Coterra Energy
CTRA • Vol: 73,319,495
Cboe Global Markets
CBOE • Vol: 5,000,011
HP
HPQ • Vol: 29,259,826